Vanguard Group Inc Lantern Pharma Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding LTRN
# of Institutions
41Shares Held
1.26MCall Options Held
42.8KPut Options Held
5.6K-
New Edge Advisors, LLC New Orleans, LA157KShares$592,3570.01% of portfolio
-
Geode Capital Management, LLC Boston, MA86.3KShares$325,5280.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.8KShares$308,3860.0% of portfolio
-
Cm Management, LLC80KShares$301,6000.35% of portfolio
-
Davenport & CO LLC63.8KShares$240,5780.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $40.8M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...